| [1] |
Wells GA, Shea B, O'connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses[EB/OL]. 2012.
URL
|
| [2] |
Langer I, Guller U, Viehl CT, et al. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study[J]. Indian J Surg Oncol, 2010, 1(1): 59-67.
|
| [3] |
Pepels MJ, de Boer M, Bult P, et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells[J]. Ann Surg, 2012, 255(1): 116-121.
|
| [4] |
Guenther J, Hansen NM, Difronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes[J]. Arch Surg, 2003, 138(1): 52-56.
|
| [5] |
Gloyeske NC, Goreal W, O'neil M, et al. Outcomes of breast cancer patients with micrometastases and isolated tumor cells in sentinel lymph nodes[J]. In Vivo, 2011, 25(6): 997-1001.
|
| [6] |
Tvedskov T, Jensen M-B, Ejlertsen B, et al. Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes: a nationwide study[J]. Breast Cancer Res Treat, 2015, 153(3): 599-606.
|
| [7] |
Cyr A, Gillanders WE, Aft RL, et al. Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden[J]. Ann Surg Oncol, 2010, 17(3): 303-311.
|
| [8] |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-1474.
|
| [9] |
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J]. 中国癌症杂志, 2017, 27(9): 695-759.
|
| [10] |
Hansen NM, Grube B, Ye X, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer[J]. J Clin Oncol, 2009, 27(28): 4679-4684.
|
| [11] |
Imoto S, Ochiai A, Okumura C, et al. Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining[J]. Eur J Surg Oncol, 2006, 32(10): 1175-1179.
|
| [12] |
Pugliese MS, Beatty JD, Tickman RJ, et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories[J]. Ann Surg Oncol, 2009, 16(1): 113-120.
|
| [13] |
Cox C, Kiluk J, Riker A, et al. Significance of sentinel lymph node micrometastases in human breast cancer[J]. J Am Coll Surg, 2008, 206(2): 261-268.
|
| [14] |
de Boer M, van Deurzen CH, van Dijck JA, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer[J]. N Engl J Med, 2009, 361(7): 653-663.
|
| [15] |
Huang TW, Kuo KN, Chen KH, et al. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system[J]. Int J Surg, 2016, 34: 73-80.
|
| [16] |
Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol, 2013, 14(4): 297-305.
|